F

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Senior Software Engineer 2 - Trial Engine

AI Application EngineeringConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • At least 7 years of experience building production software, including hands-on experience shipping software for use in a clinical trial.
  • Familiarity with clinical systems and data flows and understanding of the operational realities of delivering software into an active trial environment.
  • Familiarity with software delivery in a regulated or controlled environment, including GxP/GCP, computer system validation, requirements traceability, audit trails, electronic signatures, and change control.
  • Ability to identify when regulated-delivery considerations matter and work effectively with QA and validation partners.
  • Ability to translate regulatory requirements into compliant, well-engineered software.
  • Experience writing clean, maintainable code and knowledge of distributed systems and cloud fundamentals, including AWS, GCP, or Azure.
  • Daily use of AI tools, including large language models, agentic workflows, and retrieval pipelines, and interest in responsibly applying them in regulated clinical work.
  • Track record of technical ownership at senior scope, including multi-quarter efforts, cross-functional dependencies, and designs used by other engineers.
  • Ability to communicate effectively with non-engineers and align on approaches with clinical operations and QA stakeholders.
  • Comfort working with ambiguity and changing trial portfolios and roadmaps.

Responsibilities

  • Drive and own the design, delivery, and operation of differentiated production software used in live clinical trials, from site startup and activation through data collection, monitoring, and close-out.
  • Bring clinical, regulatory, data, and infrastructure partners together to resolve cross-functional dependencies and take software from technical design through validated use in active trials.
  • Build within a validated software development lifecycle; partner with QA and computer system validation experts to translate validation requirements into traceable, testable software and improve compliant engineering workflows.
  • Design and ship AI-native trial execution capabilities, including agents and pipelines that read clinical and operational source data to surface signals, discrepancies, and tasks, with provenance, audit trails, and human review.
  • Build integrations across clinical systems and vendors, including electronic data capture, clinical trial management systems, electronic trial master files, contract research organization and lab data feeds, and safety systems; turn fragmented inputs into a coherent, queryable trial picture.
  • Own trial-specific domain logic and software built on clinical data, partnering with Data Engineering on shared ingestion, orchestration, warehouse, quality, and governance capabilities that clinical teams can trust and that can withstand inspection.
  • Build tooling that allows trial activities traditionally performed sequentially to start earlier or run in parallel.
  • Recognize when GxP considerations apply, involve QA and validation partners early, and translate their requirements into practical engineering approaches.
  • Set technical direction, review designs, mentor engineers and other builders, and build guardrails and automation that enable the organization to move quickly and safely.

About the Company

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Formation Bio uses an AI-driven platform to speed up drug development by focusing on clinical-stage assets. It acquires and advances these assets using flexible financing structures, aiming to shorten timelines and cut costs for bringing new drugs to market. The core product is the proprietary AI tools that help with drug selection, development planning, and improving overall efficiency, enabling partnerships and successful commercialization with pharmaceutical and biotech companies. Compared with competitors, Formation Bio combines a data-powered approach with adaptable financing and asset acquisition strategies to move assets forward quickly and cost-effectively. The goal is to make treatments more accessible and affordable by accelerating development and enabling faster, more predictable commercialization through AI-enhanced decision making and flexible funding options.

Company size
51-200
Company stage
Series D
Total funding
$530.3M
Headquarters
New York City, New York
Founded
2013

Recently Posted Jobs

Explore more opportunities at Formation Bio

See more jobs